Stockscreener 앱 받기
13.06
4.31%
0.54
시간 외 거래:
13.16
0.10
+0.77%
Generate Biomedicines Inc (GENB) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2026-06-30 | 2026-03-31 |
| 기간 | 3개월 | 3개월 |
| Revenues |
12.60%
6.314
|
7.224 |
| Operating Expenses |
9.24%
77.93
|
71.34 |
| Depreciation and Amortization |
2.23%
3.20
|
3.273 |
| Operating Income/Loss |
11.70%
-71.61
|
-64.11 |
| Nonoperating Income/Loss |
81.86%
4.412
|
2.426 |
| Income/Loss From Continuing Operations Before Tax |
8.94%
-67.20
|
-61.69 |
| Income Tax Expense/Benefit |
89.29%
0.053
|
0.028 |
Net Income/Loss
|
8.98%
-67.25
|
-61.71 |
| Attributable To Noncontrolling Interest |
100.00%
-
|
-0.268 |
| Basic Average Shares |
97.68%
128.24
|
64.87 |
| Diluted Average Shares |
97.68%
128.24
|
64.87 |
| Basic Earnings Per Share |
51.40%
-0.52
|
-1.07 |
| Diluted Earnings Per Share |
51.40%
-0.52
|
-1.07 |
1.50%
자본화:
|
볼륨(24시간):